Trial Profile
Glivec in treating Philadelphia chromosome/BCR-ABL1 positive patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 06 Sep 2017 New trial record